©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112838
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112838
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112838
Figure 3 Impact of the R-spondin 3 expression on recurrence-free survival and overall survival in two independent series of colorectal cancer patients.
Kaplan-Meier plots showing recurrence-free survival and overall survival of colorectal cancer patients based on R-spondin 3 gene expression. A: Data from The Cancer Genome Atlas colon and rectal cancer cohort, analyzed using the UCSC Xena platform (https://xena.ucsc.edu); B: Data analyzed with the Kaplan-Meier Plotter tool (https://kmplot.com). P values and hazard ratios reported by each tool are shown. HR: Hazard ratio; RFS: Recurrence-free survival; OS: Overall survival.
- Citation: Tur R, Abad M, Filipovich E, Rivas MB, Rodriguez M, Montero JC, Sayagués JM. RSPO3 rearrangements in advanced colorectal cancer patients and their relationship with disease characteristics. World J Gastrointest Oncol 2025; 17(11): 112838
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/112838.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.112838